Dr Hilary Burton
Hilary Burton, a founding member of the PHG Foundation, was Director from 2010 to 2017. After stepping down as Director, she held the position of Consultant in Public Health until formally retiring from the organisation on 1 April 2019. As an Associate, Hilary will be working on My Healthy Future and our work on personalised prevention in breast cancer.
Hilary is a highly experienced public health physician who believes that genomic science can, and should be used by public health professionals alongside the social and environmental determinants of health to bring about improvements in population health. Her special interests include the integration of genomics within mainstream medicine, genetics education for health professionals, and genomics and the developing world.
Hilary trained at St Hugh’s College and The Radcliffe Hospital, Oxford and became a consultant in public health medicine in 1993. She was a member of the Department of Health’s Human Genomics Strategy Group and currently serves on the Joint Committee of Medical Genetics of the Royal Colleges and the Council for the British Society of Human Genetics. She is a Fellow of Hughes Hall, Cambridge, and holds an Honorary Lectureship at the University of Cambridge.
- Reports
-
Personalising breast cancer prevention – bridging the gap between research and policy
-
Personalised prevention in breast cancer – the policy landscape
-
Genetic screening programmes: an international review of assessment criteria
-
Genetics and mainstream medicine: service development and integration
-
Independent response to House of Lords Science and Technology Committee Genomic Medicine report
-
Tay Sachs Disease carrier screening in the Ashkenazi Jewish population
-
Heart to Heart: inherited cardiovascular conditions services
-
Evaluation of array-CGH for chromosomal abnormalities in clinical practice
- Blogs
-
Nutrigenomics - looking at the individual within their nutritional environment
-
Clinical proteome analysis - the key to personalised medicine
-
Impact of In Vitro Diagnostic Devices regulatory reforms on genetic testing
-
Alzheimer's disease - a paradigm for personalised prevention?
-
PanelApp – the catalyst to drive improved gene panel testing?
-
Infection control leads the way for the use of pathogen genomics
-
This time, it’s personal: health policy and disease prevention
-
The Spending Review: why health and care will not go hungry - yet
-
Responsible, proportionate data sharing for better and safer genetic services
-
Complex diseases need complex solutions – including genomics
-
NHS uptake of innovations: clinical researchers are not the answer
-
FSA report brings wider failure to implement pathogen genomics into focus
-
Personalised medicine in the US: does higher spending mean better care?
-
Our genomes unite us all...but can they unite the health service?
-
Epigenome analysis: Another tool in the personalised medicine kit?
-
The global battle against AMR - can technology lead the way?
-
Precision cancer medicine - close at hand or just out of reach?
-
All patients need faster access to useful medical innovations
-
Proposed EU Data Protection reform and public health genomics
-
Public Health England Initiative for Infectious Disease Genomics
-
Introducing the Cloud Infrastructure for Microbial Bioinformatics (CLIMB)
-
A commentary on Khoury & Galea Will Precision Medicine Improve Population Health
-
Implantable biosensors – is the future continuous monitoring?
-
Nanomedicine: laying tiny foundations for a big future in personalised medicine
-
Pathology and patient perspectives for clinical genomics policy
-
Welcome UK moves to revolutionise uptake of innovations in healthcare
-
Under-represented community genomics; East London takes centre stage
- News
- Journal papers
-
Moorthie S, Babb de Villiers C, Burton H, Kroese M, Antoniou A.C., Bhattacharjee P, Garcia-Closas M, Hall P, Schmidt M.K.. Preventive Medicine, Vol 159. 6 May 2022.
-
Risk stratification, genomic data and the law.
Hall A, Finnegan T, Chowdhury S, Dent T, Kroese M, Burton H.
J Community Genet. 2018; https://doi.org/10.1007/s12687-018-0358-4. [Epub ahead of print]
-
Warren-Gash C, Kroese M, Burton H, Pharoah P.
Hered Cancer Clin Pract. 2016 Jun; 1;14:12.
-
Preparing clinicians for genomic medicine
Burton H, Slade I.
Postgrad Med J. 2016 Jul;92(1089):369-71. doi: 10.1136/postgradmedj-2016-133962. Epub 2016 Mar 21.
-
Personalized medicine: what's in a name?
Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G, Stewart A.
Personalised Medicine. 2014; 11(2):197-210.
-
Moorthie S, Cameron L, Sagoo G, Bonham J, Burton H.
Journal of Inherited Metabolic Disease. 2014 Nov; 37(6):889-898.
-
The impact of genetics on public health practice
Abubakar I, Burton H, Jackson C.
British Medical Bulletin. 2014 Oct; 112(1):37-46.
-
Beyond public health genomics: proposals from an international working group
Boccia S, Mc Kee M, Adany R, Boffetta P, Burton H, Cambon-Thomsen A, Cornel MC, Gray M, Jani A, Knoppers BM, Khoury MJ, Meslin EM, Van Dijn CM, Villari P, Zimmern R, Cesario A, Puggina A, Colotto M, Ricciardi W.
Eur J Public Health. 2014 Dec; 24(6):877-9.
-
Nacul L,Stewart A, Alberg C, Chowdhury S, Burton H, Darlison MW, Grollman C, Hall A, Modell B, Moorthie S, Sagoo G, .
Journal of Public Health. 2014 June; 36(2):243-50. doi: 10.1093/pubmed/fdt048 : May 10, 2013 [Epub ahead of print]
-
Personalised medicine in the UK: challenges of implementation and impact on healthcare system
Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G.
Genome Medicine. 2014 Apr 25; 6(4):28.
-
Burton H, Chowdhury S, Hall A, Pashayan N, Pharoah P.
Journal of Medical Ethics. 2014 Mar; 40(3):163-7.
-
Familial Hypercholesterolaemia: a pressing issue for European health care
Aitman T, Brice P, Burton H, Edwards C, Humphries S.
Atherosclerosis. 2013 December; 231(2): 223-226
-
Public health genomics and personalised prevention: lessons from the COGS project
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Journal of Internal Medicine. 2013 Nov; 274(5):451-6
-
Policy challenges of clinical genome sequencing
Birney E, Burton H, Cunningham F, Firth H, Hurst J, Middleton A, Wright C.
British Medical Journal. 2013 Nov 22; 347:f6845.
-
Life insurance: genomic stratification and risk classification
Burton H, Chowdhury S, Dent T, Feze I, Foulkes W, Hall A, Hamet P, Joly Y, Kirwan N, Knoppers B, Macdonald A, Pashayan N, Simard J, Van Hoyweghen I.
European Journal of Human Genetics. 2013 Oct 16. doi: 10.1038/ejhg.2013.228
-
Schuler-Faccini L, Sanseverino M, de Rocha Azevedo L, Moorthie S, Alberg C, Burton H, Chowdhury S, Sagoo G, Nacul L.
J Community Genet. 2013 Aug 30. [Epub ahead of print]
-
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Journal of Public Health (Oxf). 2013 Aug 28.
-
Public health implications from COGS and potential for risk stratification and screening
Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
Nature Genetics. 2013 Apr; 45(4):349-51 doi: 10.1038/ng.2582. PubMed PMID: 23535723
-
Incorporating genomics into breast and prostate cancer screening: assessing the implications
Burton H, Chowdhury S, Dent T, Hall A, Hall P, Lyratzopoulos G, Pashayan N, Pharoah P.
Genetics in Medicine. 2013 Feb 14 doi: 10.1038/gim.2012.167. [Epub ahead of print] PubMed PMID: 23412607.
-
Stratified cancer screening: the practicalities of implementation.
Burton H, Chowdhury S, Dent T, Eccles D, Eeles R, Hall A, Jbilou J, Lyratzopoulos G, Pashayan N, Pharoah P, Rafi I, Segnan N, T.
Public Health Genomics. 2013;16(3):94-9.
-
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine1
Burton H, Dove E, Fisher E, Masellis M, Ozdemir V, Warnich L, Wright C.
Current Pharmacogenomics and Personalized Medicine. 2012 Jan 1; 10(1);1-6.
-
Alberg C, Behr E, Burton H, Raju H, Sagoo G.
British Medical Journal. 2011 Nov 21; 343:d6966. doi: 10.1136/bmj.d6966
-
Personalised Medicine: Lessons from Birth Defects and Single Gene Disorders
Burton H, Sanderson S.
Current Pharmacogenetics & Personalised Medicine. 2011; 9(2): 80-83.
-
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
Burton H, Chowdhury S, Dent T, Duffy S, Easton D, Eeles R, Neal D, Pashayan N, Pharoah P.
British Journal of Cancer. Advance online publication, 2011 April 5; doi:101038/bjc2011.118
-
Legal and ethical implications of inherited cardiac disease in clinical practice within the UK
Journal of Medical Ethics. 2010; 36: 762-766.
-
A framework for the prioritization of investment in the provision of genetic tests
Alberg C, Burton H, Kroese M, Lakshman R, Whittaker J.
Public Health Genomics. 2010; 13 (7-8) 538-43.
-
Tay Sachs disease carrier testing in the UK Jewish population
Alberg C, Burton H, Levene S.
British Journal of Midwifery. 2010; 18(4):220-224.
-
Realising the benefits of genetics for health
Brice P, Burton H, Stewart A, Wright C.
The Lancet. 2010 Oct; 23;376(9750):1370-1.
-
Burton H, Stewart A. Mainstreaming genetics: a comparative review of clinical services for inherited cardiovascular conditions in the UK. Public Health Genomics. 2010;13(4):235-45. Epub 2010 Apr 15
-
Bennett C, Burke S, Burton H, Farndon P.
BMC Health Services Research. 2010 May; 14;10:125.
-
Inherited cardiovascular conditions: the challenges of genomic medicine
Alberg C, Burton H, Hall A, Inherited Cardiovascular Conditions Services , Sagoo G, Stewart A.
Heart. 2010 Mar; 96(6):474-6
-
Burton H, Ells L, Flowers J, Pencheon D, Wilkinson J.
Public Health Genomics. 2010 Mar 29; [Epub ahead of print].
-
Developing stakeholder involvement for introducing public health genomics into public policy
Adams M, Bunton R, Burton H, Schroeder-Baeck P.
Public Health Genomics. 2009; 12:11-19.
-
Adams M, Burton H.
Public Health Genomics. 2009; 12(4):216-24.
-
A new strategic phase for genomic medicine in UK health services
Burton H, Wright C, Zimmern R.
Genome Medicine. 2009 Oct; 12;1(10):93
-
Genetics in ophthalmology: equity in service provision?
Alberg C, Burton H, Moore T.
Journal of Public Health. 2009; doi: 10.1093/pubmed/fdp110
-
Burton H, Butterworth A, Higgins J, Sagoo G, Sanderson S, Shaw-Smith C.
Genetics in Medicine. 2009 Mar; 11(3): 139-46
-
The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis
Burton H, Wright C.
Human Reproduction Update. 2008 Oct 22 [Epub ahead of print].
-
Bennett C, Burton H, Farndon P.
Familial Cancer. 2007; 6(2):171-80
-
The frequency of inherited metabolic disorders in the West Midlands, United Kingdom
Burton H, Green A, Preece M, Sanderson S.
Archives of Disease in Childhood. 2006.
-
Burton H, Lee P, Sanderson S, Shortland G.
Journal of Inherited Metabolic Disease. 2006.
-
Medical Education. 2005; 39(3):243-4
-
Postregistration genetics education provision for nurses, midwives and health visitors
Burton H, Metcalfe A.
Journal of Advanced Nursing. 2003; 44(4):350-9
-
The NHS in the era of genetics: implications for community practitioners
Community Practitioner. 2003;76(8):288-90
-
Genetics education for nurses, midwives and health visitors
Burton H, Metcalfe A, Shuttleworth A.
Professional Nurse. 2003; 18(12):676-80
-
Health Service Journal. 2003; 113(5868):29
-
Genetics education for midwives
Burton H, Shuttleworth A.
Royal College of Midwives. 2003; 6(4):162-4
-
From Mendel to the Human Genome Project: the implications for nurse education
Burton H, Stewart A.
Nurse Education Today. 2003; 23(5):380-5
-
Genetics education for primary health care nurses
Burton H, Shuttleworth A.
Primary Health Care. 2003; 13(4):35-8